A Study to Determine the Tolerability of Intranasal LMN-301
Clinical trial NCT06030414 · COMPLETED
Trial details
- NCT number
- NCT06030414
- Sponsor
- Lumen Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-06
- Primary completion
- 2023-12-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.